Epiphora in Treated Lacrimal Drainage System Malignancy Patients – When and Whom to Treat? [Letter]

Shalin ShahDepartment of Ophthalmology, Guru Nanak Eye Centre, Maulana Azad Medical College, New Delhi, IndiaCorrespondence[email protected]

Ruchi GoelDepartment of Ophthalmology, Guru Nanak Eye Centre, Maulana Azad Medical College, New Delhi, India

References

Kornhauser T, Ponder CM, Dockery PW, et al. Timing of jones tube placement after excision of nasal or lacrimal drainage system malignancy: a survey of the American society of ophthalmic plastic and reconstructive surgery (ASOPRS). Clin Ophthalmol. 2023;17:3057–3062. doi:10.2147/OPTH.S425716
PubMed Web of Science ®Google Scholar
Song X, Wang J, Wang S, Wang W, Wang S, Zhu W. Clinical analysis of 90 cases of malignant lacrimal sac tumor. Graefes Arch Clin Exp Ophthalmol. 2018;256(7):1333–1338. doi:10.1007/s00417-018-3962-4
PubMed Web of Science ®Google Scholar
Ramberg I, Toft PB, Heegaard S. Carcinomas of the lacrimal drainage system. Surv Ophthalmol. 2020;65(6):691–707. doi:10.1016/j.survophthal.2020.04.001
PubMed Web of Science ®Google Scholar
Holliday EB, Esmaeli B, Pinckard J, et al. A multidisciplinary orbit-sparing treatment approach that includes proton therapy for epithelial tumors of the orbit and ocular adnexa. Int J Radiat Oncol Biol Phys. 2016;95(1):344–352. doi:10.1016/j.ijrobp.2015.08.008
PubMed Web of Science ®Google Scholar
Song X, He H, Zhu Y, et al. Treatment outcomes after definitive radio(chemo)therapy for 17 lacrimal sac squamous cell carcinoma. Br J Radiol. 2020;93(1115):20190633. doi:10.1259/bjr.20190633
PubMed Web of Science ®Google Scholar